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Abstract: The occurrence and removal efficiencies of the pharmaceuticals lidocaine (LDC), 
tramadol (TRA) and venlafaxine (VEN), and their major active metabolites 
monoethylglycinexylidide (MEGX), O-desmethyltramadol (ODT) and O-desmethylvenlafaxine 
(ODV) were studied at four wastewater treatment plants (WWTPs) equipped with activated 
sludge treatment technologies. In parallel to activated sludge treatment, the removal 
efficiency of the compounds in pilot- and full-scale projects installed at the WWTPs was 
investigated. Within these projects two different treatment methods were tested: adsorption 
onto powdered/granulated activated carbon (PAC/GAC) and ozonation. The metabolite 
MEGX was not detected in any sample. The concentrations of the target analytes in 
wastewater effluents resulting from activated sludge treatment ranged from 55 to 183 (LDC), 
88 to 416 (TRA), 50 to 245 (ODT), 22 to 176 (VEN) and 77 to 520 ng L−1 (ODV). In the 
pilot project with subsequent treatment with PAC/GAC, the mean concentrations of  
the analytes were between <LOQs and 30 (LDC), 111 (TRA), 140 (ODT), 45 (VEN) and 
270 ng L−1 (ODV). In the pilot project with subsequent ozonation of the effluent from the 
conventional treatment the mean concentrations were below the limit of quantification 
(LOQ) for all of the investigated compounds. The results showed limitations of activated 
sludge treatment technologies in removing the target compounds but highlighted both 
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PAC/GAC adsorption and ozonation technologies as effective post-treatment processes for 
the elimination of the target compounds from wastewater in WWTPs. Possible oxidation  
by-products formed during ozonation were not analyzed.  
Keywords: lidocaine; tramadol; venlafaxine; metabolites; ozonation; activated  
carbon adsorption 
 
1. Introduction 
The occurrence of pharmaceuticals and personal care products in the aquatic environment has 
received increasing scientific and public attention in recent years. A large number of these compounds, 
unchanged or as active metabolites, are continuously transferred into the sewage water. Their removal 
by wastewater treatment plants (WWTPs) is a major subject of concern. In a typical European WWTP, 
conventional treatment including screening, grit removal, preliminary sedimentation, activated sludge 
treatment, chemical phosphate removal and final sedimentation is used. In this way, mechanical and 
biological degradation are the only elimination processes applied. Some pharmaceuticals such as 
ibuprofen and bezafibrate have been demonstrated to be effectively removed (removal rates >95%) by 
biological wastewater treatment [1,2]. However, several pharmaceuticals are only poorly 
removed/degraded by conventional wastewater treatment [3–7], causing their continuous discharge 
into recipient waters and their presence in different water matrices at concentrations ranging from 
nanograms to low micrograms per liter [8–10]. Due to their therapeutic and biological activity, 
pharmaceutical discharges pose a great risk to the aquatic environment affecting water and  
soil-dwelling organisms. Many studies report adverse effects on different aquatic organisms after their 
exposure to pharmaceutical compounds at environmentally relevant concentrations [11–13]. An actual 
challenge in wastewater treatment is to optimize existing treatment technologies and/or to upgrade 
existing treatment plants with new end-of-pipe technologies in order to improve removal efficiencies 
of several micropollutants including pharmaceuticals. 
Many additional treatment technologies for wastewater have been discussed over the last decades. 
One of them is the chemical oxidation by ozone. Ozonation of wastewater is an end-of-pipe 
technology, which was traditionally used for disinfection purposes and just recently has been 
investigated for the removal of micropollutants. Results from both pilot- and full-scale plants using 
ozonation after the biological treatment reported removal efficiencies of about 95% for several 
micropollutants [14,15]. The major issues of concern arising from ozonation of wastewater are related 
to the formation of oxidation by-products from matrix components and transformation products from 
micropollutants [16].  
Another technology discussed for the improvement of waste water treatment is the adsorption of 
micropollutants onto activated carbon (AC), which can either be implemented as an end-of-pipe 
technology or can be added to an existing technology in a WWTP, e.g., AC in a pumped bed-membrane 
bioreactor [17,18]. The most common applications of AC for wastewater treatment are known as 
granular activated carbon (GAC) and powdered activated carbon (PAC). Both GAC and PAC had been 
commonly used for sorption of organic micropollutants like pesticides and taste compounds [19,20]. In 
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recent years, studies of AC adsorption in laboratory systems, pilot and full-scale drinking water 
treatment plants have been carried out reporting successful removal of some micropollutants including 
pharmaceuticals such as antibiotics and endocrine disrupting compounds [21–25]. There are many 
technologies available for the implementation of AC for wastewater treatment and each of them should 
be evaluated separately.  
In a previous study the continuous WWTP discharge of the non-extensively studied pharmaceuticals 
lidocaine (LDC, anesthetic), tramadol (TRA, analgesic) and venlafaxine (VEN, antidepressant), and  
their major active metabolites desmethyltramadol (ODT) and desmethylvenlafaxine (ODV) has been  
reported [7,26], denoting the need improvement of available treatment units or application of 
alternative treatment technologies, which could mitigate the exposure of the aquatic organisms to such 
pharmaceutical compounds. Recent studies have demonstrated the presence of these compounds and 
their metabolites in some rivers and lakes in Europe and North America [6,8,27,28]. So far, studies 
concerning the removal of the compounds through unconventional technologies are scarce [14,29,30]. 
The main objectives of the present study were (a) to determine the efficiency of AC adsorption and 
ozonation for the removal of LDC, TRA, VEN and their major active metabolites; (b) to compare 
removal efficiencies of the analytes using alternative treatment technologies with the removal 
efficiencies using only biological treatment; and (c) to evaluate the influence of the investigated 
unconventional technologies on different performance parameters of a WWTP. Lab-scale experiments 
were carried out and wastewater samples from pilot- and full-scale projects at four different WWTPs 
in Germany were investigated. 
2. Materials and Methods 
2.1. Chemicals  
LDC, TRA, VEN, and squalane (internal standard) were purchased from Sigma Aldrich (Steinheim, 
Germany). Monoethylglicinexylidide (MEGX) was kindly supplied by Astra Zeneca (Wedel, Germany). 
ODT, ODV and d6-TRA (internal standard) were obtained from Toronto Research Chemical Inc. 
(Toronto, Canada). The suppliers stated a chemical purity of 98% or greater for all reference 
compounds. Acetone was obtained from LS Labor Service (Griesheim, Germany) and was used as 
received. All other organic solvents were analytical grade (Carl Roth, Karlsruhe, Germany) and were 
distilled before use. Ultrapure water was generated using an Astacus ultrapure water purification 
system from MembraPure (Bodenheim, Germany). Individual stock solutions of each compound were 
prepared in methanol (1 µg µL−1). Stock solution of the internal standard squalane (1 µg µL−1) was 
prepared in hexane. Working standard solutions were obtained by appropriate dilution of stock solutions. 
2.2. Characterization of ACs and Lab-Scale Adsorption Experiments 
Textural characterization of the ACs Carbopal AP (Donau Carbon Corporation, Frankfurt am Main, 
Germany), Norit SAE Super (Norit Activated Carbon, Riesbürg, Germany), and Hydraffin XC30 
(Donau Carbon Corporation, Frankfurt am Main, Germany) was carried out by measuring the N2 
adsorption isotherms at −196 °C. Before the experiments, the samples were outgassed under vacuum at 
120 °C overnight. The isotherms were used to calculate the specific surface area, total pore volume, 
Water 2012, 4                            
 
 
653
and micropore volume evaluated applying the Dubinin-Radushkevich method [31]. Preliminary 
adsorption tests of selected analytes (LDC and TRA) onto the ACs were carried out at room 
temperature in stirred batch systems. Different amounts of the ACs (ranging from 10 to 110 mg) were 
weighed and added to glass beakers containing 200 mL aqueous solutions of each compound. Due to 
the high adsorption capacities of the activated carbons, high initial concentrations of 100 mg L−1 of the 
pollutants were used in the batch experiments. The solutions were allowed to shake for 72 h at a 
constant temperature. The amount adsorbed was determined according to Qt = (C0 − Ct)V/m, where Qt is 
the amount (mg g−1) adsorbed at time t, C0 is the initial concentration (mg L−1), Ct is the concentration at 
time t (mg L−1), V is the volume (L) of the adsorbate solution and m is the weight (g) of the activated 
carbon. All adsorption assays and the corresponding blank experiments were made in duplicate. 
2.3. Projects at the WWTPs and Sample Collection 
Pilot- and full-scale projects at four different German WWTPs located in Langen (WWTP-A), 
Kaarst (WWTP-B), Schwerte (WWTP-C) and Wuppertal (WWTP-D) were investigated in this study 
over the period from June to October 2011. The schematic diagrams and the various sampling points 
are shown in Figure 1, while details regarding population served, applied treatment technologies, 
characteristics of installed projects at the WWTPs and operational settings during sample collection are 
summarized in Table 1. The yearly treatment volumes of the WWTPs vary from ca. 3 to 47 million m3 a−1. 
The installed technologies at all of the investigated WWTPs include mechanical, chemical and 
biological treatment. WWTP-A, WWTP-C and WWTP-D use conventional activated sludge 
wastewater treatment, including a secondary clarifier after the aeration tank. After the secondary 
clarifier the WWTP-D has a flocculation system consisting of 28 filter chambers, in which sludge and 
residual solids formed by the addition of a soluble iron compound are filtered. The WWTP-B uses a 
membrane bioreactor (MBR) as biological step, substituting the secondary clarifier of a conventional 
WWTP by membranes.  
The project at the WWTP-A consists of a pilot-scale plant, where effluent from the secondary 
clarifier is treated by two parallel technologies: PAC adsorption coupled to membrane filtration  
(PAC-MEM), and down flow fixed-bed columns filled with GAC (GAC-columns). From the second 
clarifier, treated wastewater is continuously pumped through a microfilter with a mesh size of ca. 0.3 
mm and then deposited in a stirred collection tank. From this tank the wastewater is pumped to each 
investigated treatment system. The PAC-MEM system consists of a stirred contact tank (1 m3), in 
which the PAC Carbopal AP is mixed with the biologically treated wastewater, followed by a hollow 
fiber ultrafiltration membrane (membrane pore size = 0.1 µm). The GAC-columns system operating in 
parallel at the WWTP-A, consists of two acrylic glass columns filled each one with 9.6 kg of GAC 
Hydraffin XC30. Another filter with a mesh size of ca. 0.1 mm is installed before the GAC columns. 
Each column has an internal diameter of 14.5 cm and an active length of 127 cm, resulting in a bed 
volume of 21 L.  
In the project at the WWTP-B (PAC-in-MBR), the wastewater influent is pumped into a pilot-scale 
MBR (685 L). Experiments are conducted adding PAC Carbopal AP to the ultrafiltration membrane 
module in the MBR [membrane pore size = 0.05 µm (manufacturer’s data)], which attempts to 
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reproduce the operation conditions of the MBR at the WWTP-B [membrane pore size = 0.04 µm 
(manufacturer’s data)].  
Figure 1. Schematic diagrams of the selected WWTPs (a) WWTP-A; (b) WWTP-B;  
(c) WWTP-C; (d) WWTP-D and the pilot-/full-scale projects. Sampling points are 
indicated by a cross.  
(a) (c) 
(b) (d) 
Experiments are performed at the full scale project at the WWTP-C. WWTP-C influent wastewater 
is evenly distributed between two conventional treatment systems with similar dimensions and 
operational settings. The effluent from one of these systems is discharged into the river. A fraction of 
the effluent of the other system (the difference between the maximum hydraulic loading of the 
secondary clarifier and the amount of wastewater by dry weather) is pumped to an ozonation plant 
consisting of six reactors (192 m3) dosing O3 per liter of wastewater. Thereafter, wastewater flows into 
a PAC-adsorption system consisting of three stirred tank reactors (450 m3). The adsorbent is the PAC 
Norit SAE Super. After spending time in the stirred tank reactors, the wastewater/PAC mixture is 
pumped into the nitrification stage at the aeration tank. 
The full-scale project at the WWTP-D (PAC-in-floc) consists of adding PAC Norit SAE Super to 
one filter chamber of the flocculation unit. In the filter chamber, the PAC is retained in the different 
heights of the filter bed and quantitatively removed every 24 h by the filter backwash. 
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Seven-day composite samples of the WWTP-A effluent (Aef, n = 4), the permeate of the PAC-MEM 
system (APAC-MEM, n = 4) and effluent of the GAC columns (AGAC, n = 4) were collected for analysis. 
Aef, APAC-MEM and AGAC samples were initially adjusted to a pH < 2 in order to avoid possible further 
degradation in the flask collection due to the relative long collection period. Unfortunately, due to 
technical difficulties it was not possible to collect WWTP-A influent samples in the same way as the 
other samples at Aef, APAC-MEM and AGAC. For this reason, twenty-four-hour composite samples of the 
WWTP-A influent (Ain, n = 2) and of Aef (n = 2) were additionally collected in order to calculate the 
removal efficiencies of the target analytes by conventional wastewater treatment. 
Table 1. Characteristics, operating conditions and description of the pilot- and full-scale 
projects at the investigated WWTPs during the sampling collection. 
Characteristics 
WWTPs 
WWTP-A WWTP-B WWTP-C WWTP-D 
Treatment technology 
Conventional activated 
sludge 
Membrane bioreactor 
(MBR) 
Conventional activated 
sludge 
Conventional activated 
sludge 
Sampling period 01/08/2011−06/09/2011 01/09/2011−06/10/2011 08/08/2011−18/08/2011 09/08/2011−15/08/2011 
Population served (PE) 74,000 69,000 50,000 370,000 
Average flow (m3/a) 6,000,000 5,500,000 6,000,000 47,000,000 
Wastewater type 98% R, 2% I 98% R, 2% I 92% R, 8% I 81% R, 19% I 
Collection system Combined Combined Combined Combined 
HRT (h) 18 28.5 38 51 
SRTsludge (d) 25–30 26 22 12 
T (°C) 19.4 17.5 19.7 18.4 
Characteristics 
Investigated projects at each WWTP 
1. PAC adsorption followed 
by membrane filtration  
(PAC-MEM)  
2. GAC columns 
MBR-PAC 
integrated system 
(PAC-in-MBR) 
Ozonation followed by 
PAC-adsorption 
PAC adsorption in 
flocculation system 
(PAC-in-floc) 
Dimension Pilot-scale Pilot-scale Full-scale Full-scale 
Project PAC-MEM GAC-columns PAC-in-MBR Ozonation PAC-ad. PAC-in-floc 
AC type 
Carbopal 
AP 
Hydraffin 
XC30 
Carbopal AP - 
Norit SAE 
Super 
Norit SAE Super 
AC dosage (mg AC/L 
of wastewater) 
5 - 10 - 15 20 
Transferred ozone dose 
(mg O3/L of 
wastewater) 
- - - 0.6 - - 
HRT (h) 0.9 - 24 0.4 0.9 0.4 
SRTcarbon (day) 1 - 25a - 22a 0.5 
EBCT (h) - 0.4 - - - - 
a SRT of the AC with the activated sludge; PE: population equivalent; R: residential; I: industrial/commercial;  
HRT: hydraulic retention time; SRT: solid retention time; EBCT: empty bed contact time.  
Twenty-four-hour composite samples were collected at the other investigated WWTPs. At WWTP-B: 
influent (Bin, n = 4), effluent from the MBR (Bef, n = 4) and permeate of the PAC-in-MBR (BPAC, n = 4) 
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were collected. At WWTP-C samples collected were: influent (Cin, n = 8), effluent from the 
conventional treatment (Cef, n = 8), effluent from ozonation unit (Cozon, n = 8), effluent from the  
PAC-adsorption system (CPAC, n = 8) and final effluent from the secondary clarifier containing 
wastewater treated by ozonation and PAC-adsorption units (Ceff, n = 8). At WWTP-D investigated 
samples were: influent (Din, n = 6), effluent from the secondary clarifier (Def, n = 6), effluent from a 
filter chamber of the flocculation system with no addition of PAC (Dfloc, n = 6) and effluent from the 
filter chamber, to which PAC was added (DPAC, n = 6). Samples were collected simultaneously in the 
sample locations at each WWTP using automatic samplers (time-proportional) and then stored in brown 
glass bottles and cooled at 4 °C in the dark until processing in laboratory within 7 days after sampling. 
2.4. Analytical Methods 
Target analytes were extracted from the wastewater samples (untreated wastewater: 250 mL, 
wastewater treated by conventional technologies: 500 mL, wastewater treated by unconventional 
technologies: 1 L) by solid phase extraction (SPE) using Bond Elute PPL cartridges (100 mg/1 mL, 
Varian, Darmstadt, Germany). Samples from the sampling locations at the WWTP-A were neutralized 
to pH between 7.2 and 7.5 by addition of a NaOH solution before SPE. Water samples were filtered by 
pressure filtration using 1 µm borosilicate glass fiber filter (Type A/E, Pall, Dreieich, Germany) prior 
to SPE. Cartridges were eluted with methanol/acetone (1/1, v/v) and extracts were dried and dissolved 
in methanol. Squalane and d6-TRA were added to the extracts as internal quantification standards. 
Quantification of the analytes in extracts was performed using a Trace GC Ultra gas chromatograph 
(equipped with a TG-5MS capillary column) coupled to a DSQ II mass spectrometer (Thermo 
Scientific, Dreieich) operated in full scan mode (m/z 50–650) with electron impact ionization (70 eV). 
See Rúa-Gómez and Püttmann [7] for a detailed description of the applied analytical method. Briefly, 
ultra pure helium (≥99.999%) was used as the carrier gas (1.1 mL min−1 flow), and the column oven 
temperature was increased from 80 to 300 °C at 4 °C min−1, and maintained for 30 min at 300 °C. 
Sample aliquots of 1 μL were injected in the splitless mode (injector temperature 240 °C). Acquired 
data were processed using Xcalibur software Version 2.0.7 (Thermo Scientific, Dreieich, Germany). 
Samples were collected in 1-L brown glass bottles. These were rinsed before use with ultrapure 
water and methanol and then heated to 110 °C for a minimum of 2 h. Before use glass fiber filters were 
washed with dichloromethane and then heated in an oven for 2 h at 400 °C. Blank samples, consisting 
of ultrapure water, were extracted and treated in the same way as field samples to test for sample 
contamination during transportation and preparation.  
In accordance with DIN 32645 German Institute for Standardization [32] limit of detection (LOD) 
for LDC, TRA, VEN and the metabolites MEGX, ODT and ODV was calculated from measured 
calibration curves. The limit of quantification (LOQ) was estimated as three times the LOD and 
provided values of 16 (LDC), 50 (MEGX), 25 (TRA), 18 (VEN), 35 (ODT) and 23 ng L−1 (ODV). 
Recovery rates were calculated for the entire method by spiking the target analytes into 1-L 
groundwater samples (n = 6), 0.5-L treated wastewater samples (n = 6) and 0.2-L untreated wastewater 
samples (n = 6), at a spiking level of 200 ng L−1. Mean recoveries in groundwater were: 81 ± 5% (LDC), 
59 ± 3% (MEGX), 82 ± 7% (TRA), 94 ± 9% (VEN), 71 ± 9% (ODT) and 94 ± 4% (ODV); in treated 
wastewater: 66 ± 8% (LDC), 53 ± 8% (MEGX), 64 ± 5% (TRA), 82 ± 5% (VEN), 59 ± 4% (ODT) and 
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86 ± 4% (ODV); and in untreated wastewater: 56 ± 4% (LDC), 49 ± 9% (MEGX), 61 ± 6% (TRA),  
79 ± 6% (VEN), 51 ± 9% (ODT) and 71 ± 11% (ODV). No adjustments to concentrations in the 
samples were made in regard to the SPE recovery rates. 
After equilibration, LDC and TRA concentrations in the solutions from the lab-scale adsorption 
tests were determined using a UV-VIS spectrophotometer UVPC2400 (Shimadzu, Duisburg, 
Germany) equipped with tungsten and deuterium lamps as light sources. After calibration of the 
instrument for each analyte, detection wavelength was set to 230 nm (LDC) and 270 nm (TRA).  
Conventional physicochemical parameters of WWTP samples [Chemical Oxygen Demand (COD), 
total nitrogen (TN) as the sum of ammonium, nitrite and nitrate nitrogen, total phosphorus (TP) and 
dissolved organic carbon (DOC)] were determined according to standard methods indicated by the 
German Federal Ministry of Justice [33]. 
3. Results and Discussion  
3.1. Occurrence and Removal of Target Analyses through Activated Sludge Treatment 
Concentrations of the target analytes found in each sampling location at the investigated WWTPs 
are shown in Figure 2. The pharmaceuticals LDC, TRA and VEN and the metabolites ODT and ODV 
were detected above the LOQ in all of the influent and effluent samples from the activated sludge 
treatment, while MEGX, the metabolite of LDC, as expected in accordance with a previous study, was 
not detected in any sample. The concentrations of the investigated pharmaceuticals varied from  
70 to 257 (LDC), 232 to 615 (TRA), 60 to 299 (ODT), 54 to 336 (VEN), and 235 to 723 ng L−1 (ODV) 
in the WWTP influents, whereas the concentrations in the effluent samples ranged from 55 to 183 (LDC), 
88 to 416 (TRA), 50 to 245 (ODT), 22 to 176 (VEN) and 77 to 520 ng L−1 (ODV). Although a 
reduction in the concentrations of the target analytes was observed, the continuous discharge of the 
target analytes at these effluent concentrations into surface waters could cause adverse effects on the 
aquatic environment. A recent study has shown that concentrations of VEN at picogram per liter levels 
cause significant foot detachment from the substrate in freshwater snails, a sublethal effect that could 
have lethal consequences for these species [13]. Moreover, the potential toxicological effects caused 
by the interaction of different pharmaceuticals (among many other compounds present in wastewater 
effluents) cannot be discarded [34].  
Due to their physiochemical characteristics (high water solubilities, low n-octanol/water partition 
coefficients and low Henry coefficients) all target analytes are expected to be found in the water phase 
rather than being volatilized or retained in the activated sludge [7]. Thus, elimination of the 
compounds achieved by activated sludge treatment corresponded to the difference between influent 
and effluent mass loads of the target analytes in the water phase. Removal efficiencies of the target 
analytes obtained by activated sludge treatment at the investigated WWTPs are presented in Table 2. 
The removal efficiencies of the target analytes obtained in each WWTP are difficult to compare, since 
the investigated WWTPs work with different operational settings and have different influent 
characteristics (see Table 1). The removal rates reported for the WWTP-A and WWTP-D indicate 
mechanical and biological treatment because the influent samples were collected before the first 
settling tank (at the WWTP-A) and before the screening step (at the WWTP-D). The WWTPs using 
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conventional activated sludge treatment, WWTP-A, WWTP-C and WWTP-D, working with different 
operational settings, showed maximal removal rates of 35% (LDC), 56% (TRA), 27% (ODT), 56% 
(VEN) and 41% (ODV). These results were consistent with the findings from a previous study 
showing maximal removal efficiencies of 37% (LDC), 41% (TRA), 24% (ODT), 48% (VEN) and 29% 
(ODV) during conventional wastewater treatment [7], confirming that the investigated pharmaceuticals 
could only be partially removed using mechanical and biological treatment. Increasing aerobic solid 
retention times (SRT) can enhance the biological degradation of various pharmaceuticals such as 
bezafibrat and ibuprofen [35]. A similar effect for the target analytes has not been observed in the 
present study. 
Figure 2. Average, maximum and minimum concentrations of target analytes along the 
treatment process at the investigated WWTPs: (a) WWTP-A; (b) WWTP-B; (c) WWTP-C; 
(d) WWTP-D. Number of samples are given in parenthesis. 
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The WWTP-B uses a combination of a membrane process with a suspended growth bioreactor as 
the biological step. This system is actually being widely used for wastewater treatment, as it allows 
smaller sludge aeration basin volume, exceeds significantly the efficiency of conventional sand 
filtration and presents higher SRTs above the levels that can be obtained with secondary clarifiers [1,36]. 
However, removal efficiencies of the target compounds obtained by this treatment system were also 
insufficient (Table 2).  
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Table 2. Percentage of removal of target analytes during activated sludge treatment at the 
investigated WWTPs. 
WWTP 
% Removal 
LDC TRA ODT VEN ODV 
WWTP-A 29 43 27 40 39 
WWTP-B 25 20 21 37 29 
WWTP-C 14 36 17 40 31 
WWTP-D 35 56 21 56 41 
In activated sludge treatment, two mechanisms are considered for the removal of micropollutants from 
wastewater: adsorption on the sludge and degradation by microorganisms. Poor removal efficiencies of 
the target analytes achieved during activated sludge treatment (conventional and in a MBR) may be 
explained by the tendency of the compounds to remain in the water phase, which suppresses their 
sorption onto the sludge. Thus, the most plausible mechanism for the removal of the investigated 
compounds from wastewater seems to be the degradation by bacteria present in the sludge, which have 
been previously reported for other pharmaceuticals [37,38]. Furthermore, considering that many other 
compounds are also present in wastewater, some easier to degrade than others, a competition for the 
degradation of the compounds by the bacteria is expected to take place, thereby decreasing the removal 
efficiencies of the target analytes [39].  
3.2. Removal of Target Analytes through Unconventional Technologies 
3.2.1. Adsorption Experiments 
Selected textural characteristics of the ACs used are summarized in Table 3. All three selected 
carbons showed similar porous features, with well-developed micro/mesoporosity as indicated by the 
type I/IV N2 adsorption isotherms (data not shown). Some small differences concerning the pore 
volumes were observed; for instance, micropore volumes are rather close for the three activated 
carbons, whereas a slightly higher total pore volume was measured for PAC Norit SAE Super. It is 
well known that micropores are the active sites for the retention of micropollutants in both gas and 
liquid phase and that the transport pores (mesopores) and average particle size mainly affect the 
adsorption kinetics [40]. Bearing this in mind, it can be expected that these carbons would show 
similar adsorptive behaviors. Additionally, further characterization of the carbons confirmed that these 
adsorbents have a hydrophobic nature. 
Table 3. Physical features of the used ACs. 
Characteristics Carbopal AP Hydraffin XC30 Norit SAE super 
Type PAC GAC PAC 
Avg. particle size diameter (µm) 33.6 1400 15 
SBET (m2 g−1) 899 1036 965 
VT (cm3 g−1) 0.524 0.619 0.69 
Wo (cm3 g−1) 0.40 0.44 0.40 
SBET: specific surface area evaluated from the BET equation; VT: total pore volume evaluated at p/po 0.95; 
Wo: micropore volume evaluated applying the Dubinin-Radushkevich equation. 
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The lab-scale adsorption test data for the investigated ACs were fitted to both Freundlich and 
Langmuir models (Table 4), with higher correlation coefficients for the Langmuir equation. For all of 
the activated carbons higher adsorption capacities of LDC were obtained in comparison to TRA, which 
is in good agreement with the expected trend based on their chemical composition and size. No 
information about LDC and TRA adsorption on AC could be found in the literature for comparison. 
Nevertheless, more relevant to our study was the fact that the preliminary test data confirmed the 
adsorption of the selected micropollutants onto AC.  
Table 4. Fitting parameters to the Langmuir and Freundlich models of the equilibrium 
adsorption isotherms (at 25 °C) of lidocaine (LDC) and tramadol (TRA) onto the activated 
carbons used in this study.  
Activated carbon 
Freundlich isotherms constants Langmuir isotherm constants 
KF (mg g−1/(mg L−1)1/n) 1/n r2 qm (mg g−1) KL (L mg−1) r2 
LDC 
Carbopal APa 137 0.13 0.773 215 0.81 0.998 
Hydraffin XC30-Aa 56 0.31 0.918 196 0.17 0.997 
Hydraffin XC30-Bb 89 0.27 0.851 246 0.28 0.999 
Norit SAE Supera 156 0.06 0.980 204 0.79 0.999 
Activated carbon TRA 
Carbopal APa 46 0.15 0.964 84 0.36 0.995 
Hydraffin XC30-Aa 25 0.23 0.965 76 0.10 0.999 
Hydraffin XC30-Bb 29 0.23 0.948 85 0.15 0.999 
Norit SAE Supera 61 0.08 0.987 87 0.39 0.999 
a contact time of 72 h; b contact time of 120 h;  Freundlich isotherm: qe = KF (Ce)1/n; Langmuir isotherm:  
qe = (KL·qm· Ce)/(1+KL·Ce); qe: amount adsorbed per unit mass of adsorbent; Ce: equilibrium concentration of 
compound in liquid; qm = maximum adsorption capacity KF: Freundlich coefficient; KL: Langmuir coefficient. 
Despite the similarities in the chemical and porous features of the carbons (Table 3), slightly higher 
adsorption capacities were obtained for Carbopal AP and Norit SAE Super, compared to Hydraffin 
XC30. This is attributed to the different adsorption kinetics as a result of the particle size diameter of 
the carbons. Indeed, the lab-scale adsorption tests were carried out after 72 h of contact between the 
carbon/solution suspensions. Under these conditions, kinetic studies (data not shown) revealed the 
slow uptake of the GAC system compared to PAC, thereby resulting in slightly lower adsorption 
capacity (lower than the theoretical expected uptake at equilibrium conditions for this carbon). This 
was further confirmed by the increase in the uptake (qm parameter from Langmuir model) when the 
contact time is risen up to 120 h, obtaining values in agreement with the porosity of the carbons. 
3.2.2. Projects PAC-MEM and GAC-columns 
In the final effluent of the system PAC-MEM at the WWTP-A, the target analytes were found at 
mean concentrations of 30 (LDC, VEN), 106 (TRA), <LOQ (ODT) and 139 ng L−1 (ODV), whereas 
the mean concentrations found in the effluent of the system consisting of fixed-bed columns filled with 
GAC were below the LOQ for all of the compounds (Figure 2). The decrease in the concentrations 
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compared with the concentrations in the WWTP-A effluent showed the adsorption of the target 
analytes both onto PAC and GAC.  
Removal efficiencies of the target analytes observed in both investigated systems at the WWTP-A are 
listed in Table 5. Higher removal efficiencies were obtained during treatment with the GAC-columns 
than during treatment in the PAC-MEM system. These results are in good agreement with the 
expectation based on the porous features (Table 3) and the lack of restricted diffusion, thus confirming 
the suitability of the GAC in the fixed-bed columns. 
Table 5. Percentage of removal of the target analytes obtained by the unconventional 
treatment systems at the investigated WWTPs. 
Treatment system 
LDC TRA ODT VEN ODV 
%RUP %Rtotal %RUP %Rtotal %RUP %Rtotal %RUP %Rtotal %RUP %Rtotal
WWTP-A 
PAC-MEM 68 77 47 70 >80 >88 51 67 56 74 
GAC columns >72 >93 >90 >97 >80 >88 >70 >90 >92 >98 
WWTP-B 
PAC-in-MBR - 87 - 81 - 47 - 85 - 52 
WWTP-C 
Ozonation >89 >91 >95 >97 >84 >87 >80 >88 >95 >97 
PAC-adsorption nc >91 nc >97 nc >87 nc >88 nc >97 
Secondary clarifier  nc >91 nc 93 nc >87 nc >88 nc 85 
WWTP-D 
Flocculation system 4 37 2 55 5 28 2 56 5 44 
PAC-in-floc 76 84 72 88 73 79 73 87 71 85 
RUP: Removal efficiency of the specific unit process; Rtotal: Removal efficiency after activated sludge treatment and 
the respective unit process; nc: not calculated because of values below the LOQ in the wastewater entering the unit 
process. For the data below the LOQ, 0.5 × LOQ was used for the calculation of the removal efficiency. 
The GAC-columns system located as a post-technology after activated sludge treatment increased 
significantly the removal efficiencies of the target analytes in the WWTP-A, achieving removal rates 
above 88% for all of the compounds. In the present work, the columns were filled with GAC about  
1 month before the collection of the samples so its adsorption capacity was not yet exhausted. It can be 
expected that, with time, the adsorption capacity of the GAC-columns will decrease and be depleted 
while biological activity will be developed in the columns contributing to degradation of the 
compounds [41]. The use of filled GAC-columns has already been reported as an effective  
post-treatment technology for the removal of several pharmaceuticals. Nguyen et al. [42] reported 
removal efficiencies ≥98% for other hydrophilic pharmaceuticals such as carbamazepine and 
diclofenac, which during activated sludge treatment showed efficiencies below 40%. 
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3.2.3. Project PAC-in-MBR 
With the addition of PAC into the MBR of the PAC-in-MBR system at the WWTP-B, the mean 
concentrations of the target analytes in the effluent were 26 (LDC), 80 (TRA), 111 (ODT), 31 (VEN) 
and 248 ng L−1 (ODV). The addition of PAC into the MBR achieved removal efficiencies of the target 
analytes (Table 5). A comparison of these values with the removal efficiencies obtained during 
activated sludge treatment at the WWTP-B (Table 2) has to be done carefully as the constant flow into 
the PAC-in-MBR system resulted in a flow-proportional sampling at BPAC, whereas sampling at Bin 
was time-proportional and no monitoring of the daily variation of wastewater was carried out at this 
sampling location. The metabolites ODT and ODV appeared to be poorly adsorbed by the PAC within 
the MBR, since the removal efficiencies after addition of PAC were also deficient. Observing the 
performance of the PAC Carbopal AP in the PAC-in-MBR system and PAC-MEM system at the 
WWTP-A, it can be concluded that the PAC Carbopal AP is not suitable for an effective removal of 
the target analytes from wastewater. The lower adsorption capacities obtained for LDC and TRA in the 
lab-scale experiments (Table 4) also support this finding, and suggest that such poor performance of 
the AC might be related to hindered accessibility of these compounds in microporous ACs. This 
statement remains an assumption as no operating settings were tested to optimize the performance of 
both systems at WWTP-A and WWTP-B. Other authors reported satisfactory results in the removal 
process of the persistent hydrophilic pharmaceuticals carbamazepine and sulfamethoxazole by 
simultaneous PAC adsorption within a MBR [18]. However, little information about the chemical 
composition and the micro/mesoporosity of therein used PAC is provided. A study of the Ministry for 
Climate Protection, Environment, Agriculture, Nature Conservation and Consumer Protection of the 
German State of North Rhine-Westphalia [43] reported high removal efficiencies of sulfamethoxazole 
from wastewater using Carbopal AP as adsorbent. Thus, the PAC-in-MBR technology and the use of 
Carbopal AP at the WWTP-B are not discarded for an effective removal of the target analytes and 
argue for further investigation.  
3.2.4. Project Ozonation Followed by PAC-Adsorption 
The samples collected after the ozonation step at the WWTP-C showed mean concentrations below 
the LOQ for all of the target analytes (Figure 2). Thus, for a dosage of 0.6 mg O3 per liter of 
wastewater (≈0.1 mg O3 mg−1 DOC during sample collection) and a contact time of 54 min, removal 
rates greater than 89% (LDC), 95% (TRA), 84% (ODT), 80% (VEN) and 95% (ODV) were calculated, 
presenting the ozonation as an effective step for removal of the selected compounds from wastewater 
after activated sludge treatment (Table 5). Removal efficiencies of LDC, VEN and ODV during 
ozonation were consistent with recently conducted studies. Hollender et al. [14] reported elimination 
rates of 98%, 99% and 96% for LDC, VEN and ODV, respectively, for a dosage of 0.6 mg O3 mg−1 
DOC and a contact time of about 9 min. An ozonation stage with a dosage of 0.5 mg O3 mg−1 DOC 
and a contact time of 15 min showed removal rates of about 88% for both TRA and VEN [29]. The 
good removal efficiencies obtained by the ozonation at the WWTP-C with low ozone dosage relative 
to the DOC content was due to the long contact time (54 min). 
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Parallel to the beneficial effects of oxidation of the target compounds, the use of ozonation can 
cause the formation of undesired by-products through the reaction of ozone and OH radicals with 
different compounds present in wastewater. As biological treatment technologies have been reported as 
an effective tool for the removal of organic by-products [14,44], it is assumed that the recirculation of 
the effluent of the PAC-adsorption system at the WWTP-C to the aeration tank contribute to the 
degradation of eventually formed organic by-products.  
No target compounds were detected in effluent samples from the PAC-adsorption system at the 
WWTP-C. Because the concentrations of the target analytes after ozonation were below the LOQs, 
removal efficiencies at the PAC-adsorption system could not be calculated. Although at the WWTP-C 
the implementation of a PAC-adsorption system after ozonation for the removal of the target analytes 
appears to be unnecessary, Reungoat et al. [29] highlighted the importance of a post-filtration with 
AC, in order to achieve total removal of different micropollutants and non-target compounds including 
transformation products. Additional to the removal of several compounds, the use of ozone in 
wastewater treatment provides disinfection, viral inactivation and sterilization of the final effluent [14]. 
The concentrations of the target analytes found in the effluent samples from the secondary clarifier 
containing wastewater treated by the ozonation and the PAC-adsorption systems were <LOQ (LDC, 
ODT and VEN), 27 (TRA) and 51 ng L−1 (ODV). The increment in the concentrations was due to the 
continuous entry of fresh wastewater influent to the aeration tank. 
3.2.5. Project PAC-in-floc 
The effluent samples from the flocculation filter chamber operated with PAC presented mean 
concentrations of 19 (LDC), 44 (TRA), <LOQ for ODT and VEN, and 71 ng L−1 (ODV), which are 
significantly lower than the concentrations found in the effluent samples from the filter chamber 
operated without PAC [108 (LDC), 157 (TRA), 97 (ODT), 50 (VEN) and 270 ng L−1 (ODV)] (Figure 2). 
Acceptable removal efficiencies were observed through the addition of PAC which increase the total 
removal of the target analytes at the WWTP-D. As expected due to the hydrophilic character of the 
target analytes, no significant elimination of these micropollutants was observed by the flocculation 
process at the WWTP-D (Table 5).  
3.2.6. Mechanisms for Adsorption onto AC and Ozonation 
The concentrations of the target analytes found in influent and effluent samples from the treatment 
systems at WWTP-A, WWTP-B and WWTP-D demonstrated the adsorption of the compounds onto 
the AC. Due to the moderately alkaline or alkaline character of the target analytes [pKa values of 8.01 
(LDC, [45]), 9.13 (TRA, [46]), 9.12 (ODT, [46]), 9.4 (VEN, [47]) and 14.46 (ODV, [48])], and the 
amino groups in their structures which under neutral conditions will be protonated forming cations [49], 
electrostatic interactions between the cations and the AC are expected to occur. However, due to the 
hydrophobic nature (basic character) of the ACs used, at neutral conditions their surface is expected to 
be neutral or slightly positive charged, for which electrostatic interactions (attractive) between the 
pollutants and the ACs are not expected to be the main driving force controlling the uptake on all three 
studied ACs [50]. Thus, the uptake strongly depends on the nature of the pollutant (i.e., boiling point, 
molecular size, solubility). 
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The ozonation step investigated at the WWTP-C showed good removal efficiencies for all of the 
target compounds. Considering that the ozonation process is dependent on the functional groups and 
that ozone reacts relatively fast with compounds containing an activated aromatic moiety, double 
bonds or amino groups [16], the removal of the target analytes during ozonation at the WWTP-C is 
explained by the tertiary amino groups present in their chemical structures.  
3.3. Evaluation of other Parameters Relevant to the Wastewater Treatment 
Parallel to the removal of the target analytes, the implications of using AC and ozonation 
technologies on different performance parameters of the WWTP were analyzed. Concentrations of the 
parameters COD, TN, TP and DOC measured at the sampling locations at WWTP-B, WWTP-C and 
WWTP-D are represented in Figure 3. Due to technical difficulties at some sampling dates, statistical 
values of COD and TP could not be calculated at WWTP-B and WWTP-D, respectively. DOC 
concentrations were measured only at sampling locations at WWTP-D. Unfortunately, performance 
parameters could not be measured during the WWTP-A sampling. The mean COD concentrations 
found in samples at Ceff and DPAC (10 and 7 mg L−1) were lower than the mean COD concentrations 
measured at Cef and Dfloc (15 and 10 mg L−1). This indicates that the addition of PAC to nitrification 
step of the aeration tank at the WWTP-C and to the flocculation filter chamber at WWTP-D enhance 
the COD removal process, and thus the overall removal of organic compounds at the WWTP. This 
affirmation can be confirmed by the mean DOC concentrations measured at Dfloc and DPAC  
([DOC]Dfloc = 5 mg L−1 > [DOC]DPAC = 3 mg L−1).  
Mean TN concentrations measured in samples from BPAC (5 mg L−1) and Ceff (6 mg L−1) were lower 
than the mean TN concentrations in samples from Bef (7 mg L−1) and Cef (8 mg L−1). The results 
showed that the addition of PAC to activated sludge processes increase the N removal at WWTP-B 
and WWTP-C. The nitrification enhancement is probably due to retention onto PAC of inhibitory 
compounds of the nitrification processes [51]. As expected due to the absence of growing bacteria in the 
flocculation chambers, no N removal was observed by addition of PAC to the flocculation chamber. 
TP concentrations in the samples from Bef and BPAC varied so that it was not possible to  
establish any tendency at the PAC-in-MBR system at the WWTP-B. A slight decrease of the TP  
concentrations at the WWTP-C by addition of PAC to the activated sludge process was observed  
([TP]Cef =0.6 mg L−1 > [TP]Ceff =0.4 mg L−1). An increase in phosphorus removal efficiencies using AC 
in activated sludge systems were reported by Serrano et al. [52]. 
The concentrations of the performance parameters measured in the final effluents after the treatment 
projects at WWTP-B, WWTP-C and WWTP-D were far below the threshold values established by the 
German Federal Ministry of Justice [33] for discharges from WWTPs magnitude 4 (WWTP-B and 
WWTP-C; 90 (COD), 18 (TN) and 2 mg L−1 (TP)) and magnitude 5 [WWTP-D; 75 (COD), 13 (TN) 
and 1 mg L−1 (TP)]. 
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Figure 3. Average concentrations and standard deviations (a) Chemical Oxygen Demand 
(COD); (b) total nitrogen (TN); (c) total phosphorus (TP); and (d) dissolved organic 
carbon (DOC) measured during sampling at WWTP-B, WWTP-C and WWTP-D. 
Threshold values of each parameter according the WWTP characteristics are indicated with 
a line [33]. 
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4. Conclusions  
Different treatment systems including adsorption onto PAC/GAC and ozonation were demonstrated 
as viable post-treatment technologies in order to enhance the removal efficiencies of LDC, TRA, VEN 
and the metabolites ODT and ODV from biologically treated wastewater at a WWTP. Lab-scale 
adsorption tests on the selected carbon adsorbents showed high removal efficiencies for LDC as 
opposed to TRA, indicating that the overall uptake is governed by several factors: the affinity of the 
pollutant towards the aqueous solution, the structural shape of the pollutants, and the adsorbent particle 
size. The removal of the target analytes using AC was explained based on their chemical nature, and 
obtained data show their adequateness to be used in post-treatments for upgrading WWTPs. In the case 
of ozonation, the removal efficiency seems to be related to the presence of tertiary amino groups in the 
chemical structure of the micropollutants. Taking into account that the concentrations of the target 
analytes in the WWTP effluents are diluted to a great extent when they are discharged into surface 
waters, it can be expected, according to the removal efficiencies obtained in this study, that the 
concentrations of the pharmaceuticals and their metabolites will be below the LOQs at the discharge 
points of WWTPs upgraded with unconventional technologies. The addition of PAC to activated 
sludge processes appears to improve other water quality parameters such as TN and COD. 
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Parallel to the removal of micropollutants, different aspects such as waste production, electricity 
consumption and operation costs will have to be discussed for the implementation of AC and 
ozonation technologies at large-scale in WWTPs. Moreover, the formation of by-products has to be 
considered in case of ozonation. 
Acknowledgments 
The first author would like to thank the Catholic Academic Exchange Service (KAAD) for financial 
support. The support of colleagues and staff of the Institute of Atmospheric and Environmental 
Sciences at the Goethe University Frankfurt am Main and of the Instituto Nacional del Carbon in 
Oviedo is gratefully acknowledged. Projects in Schwerte and Wuppertal are financial supported by the 
Ministry for Climate Protection, Environment, Agriculture, Nature Conservation and Consumer 
Protection of the German State of North Rhine-Westphalia. Thanks are due to Gregor Lorenz and 
Dieter Thöle from the Ruhrverband, Jochen Herr from the RWTH Aachen University, Peter Cornel 
and Gregor Knopp from Institut IWAR at the Technische Universität Damstadt, Helmut Volpert and 
Stefan Hoffmann from the Abwasserverband Langen-Egelsbach-Erzhausen and Catrin Bornemann 
from the Wupperverband, for sampling and for their assistance in questions about technical 
characteristics of the investigated WWTPs. COA thanks MICINN for financial support (grant 
CTM2008-01956). Thanks go to German Academic Exchange Service (DAAD) for covering traveling 
costs within the project PPP-Spain.  
References 
1. Clara, M.; Strenn, M.; Gans, O.; Martinez, E.; Kreuzinger, N.; Kroiss, H. Removal of selected 
pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and 
conventional wastewater treatment plants. Water Res. 2005, 39, 4797–4807.  
2. Smook, T.M.; Zho, H.; Zytner, R.G. Removal of ibuprofen from wastewater: Comparing 
biodegradation in conventional, membrane bioreactor, and biological nutrient removal treatment 
systems. Water Sci. Technol. 2008, 57, 1–8. 
3. Gros, M.; Petrović, M.; Barceló, D. Wastewater treatment plants as a pathway for aquatic 
contamination by pharmaceuticals in the Ebro River Basin (Northeast Spain). Environ. 
Toxicol.Chem. 2007, 26, 1553–1562. 
4. Kasprzyk-Hordern, B.; Dinsdale, R.M.; Guwy, A.J. The removal of pharmaceuticals, personal 
care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on 
the quality of receiving waters. Water Res. 2009, 43, 363–380. 
5. Palmer, P.M.; Wilson, L.R.; O’Keefe, P.; Sheridan, R.; King, T.; Chen, C.-Y. Sources of 
pharmaceutical pollution in the New York City watershed. Sci. Total Environ. 2008, 394, 90–102. 
6. Metcalfe, C.D.; Chu, S.; Judt, C.; Li, H.; Oakes, K.D.; Servos, M.; Andrews, D.M. 
Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an 
urban watershed. Environ. Toxicol. Chem. 2010, 29, 79–89. 
7. Rúa-Gómez, P.; Püttmann, W. Occurrence and removal of lidocaine, tramadol, venlafaxine and 
their metabolites in German wastewater treatment plants. Environ. Sci. Pollut. Res. 2012, 19, 
689–699. 
Water 2012, 4                            
 
 
667
8. Kasprzyk-Hordern, B.; Dinsdale, R.M.; Guwy, A.J. The ocurrence of pharmaceuticals, personal 
care products, endocrine disruptors and illicit drugs in surface water in South Wales. Water Res. 
2008, 42, 3498–3518. 
9. Peng, X.; Yu, Y.; Tang, C.; Tan, J.; Huang, Q.; Wang, Z. Occurrence of steroid estrogens, 
endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the 
Pearl River Delta, South China. Sci. Total Environ. 2008, 397, 158–166. 
10. Tixier, C.; Singer, H.P.; Oellers, S.; Müller, S. Occurrence and fate of carbamazepine, clofibric 
acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 
2003, 37, 1061–1068. 
11. Nentwig, G.; Oetken, O.; Oehlmann, J. Effects of pharmaceuticals on aquatic invertebrates—The 
example of carbamazepine and clofibric acid. In Pharmaceuticals in the Environment, Sources, 
Fate, Effects and Risks, 2nd ed.; Kümmerer, K., Ed.; Springer-Verlag: Berlin, Germany, 2004;  
pp. 195–207.  
12. Schulte-Oehlmann, U.; Oetken, M.; Bachmann, J.; Oehlmann, J. Effects of ethinyloestradiol and 
methyltestosterone in prosobranch snails. In Pharmaceuticals in the Environment, Sources, Fate, 
Effects and Risks, 2nd ed.; Kümmerer, K., Ed.; Springer-Verlag: Berlin, Germany, 2004;  
pp. 233–247. 
13. Fong, P.P.; Hoy, C.M. Antidepressants (venlafaxine and citalopram) cause foot detachment from 
the substrate in freshwater snails at environmentally relevant concentrations. Mar. Freshw. Behav. 
Phy. 2012, 45, 145–153. 
14. Hollender, J.; Zimmermann, S.G.; Koepke, S.; Krauss, M.; Mcardell, C.S.; Ort, C.; Singer, H.; 
von Gunten, U.; Siegrist, H. Elimination of organic micropollutants in a municipal wastewater 
treatment plant upgraded with a full-scale post-ozonation followed by sand filtration. Environ. 
Sci. Technol. 2009, 43, 7862–7869. 
15. Huber, M.M.; Göbel, A.; Joss, A.; Herrmann, N.; Löffler, D.; MCardell, C.S.; Ried, A.; Siegrist, H.; 
Ternes, T.A.; von Gunten, U. Oxidation of pharmaceuticals during ozonation of municipal 
wastewater effluents: A pilot study. Environ. Sci. Technol. 2005, 39, 4290–4299. 
16. Von Gunten, U. Ozonation of drinking water: Part I. Oxidation kinetics and product formation. 
Water Res. 2003, 37, 1443–1467. 
17. Dosoretz, C.G.; Böddeker, K. Removal of trace organics from water using a pumped bed-membrane 
bioreactor with powdered activated carbon. J. Memb. Sci. 2004, 239, 81–90. 
18. Li, X.; Hai, F.I.; Nghiem, L.D. Simultaneous activated carbon adsorption within a membrane 
bioreactor for an enhanced micropollutant removal. Bioresour. Technol. 2011, 102, 5319–5324. 
19. Ternes, T.A.; Joss, A. Human Pharmaceuticals, Hormones and Fragrances: The Challenge of 
Micropollutants in Urban Water Management; IWA Publishing: London, UK, 2006. 
20. Bandosz, T.J. Activated carbon surfaces in environmental remediation. In Interface Science and 
Technology; Elservier: Amsterdam, The Netherlands, 2006; Volume 7. 
21. Kim, S.H.; Shon, H.K.; Ngo, H.H. Adsorption characteristics of antibiotics trimethoprim on 
powdered and granular activated carbon. J. Ind. Eng. Chem. 2010, 16, 344–349. 
22. Ternes, T.A.; Meisenheimer, M.; Mcdowell, D.; Sacher, F.; Brauch, H.J.; Haist-Gulde, B.; Preuss, G.; 
Wilme, U.; Zulei-Seibert, N. Removal of pharmaceuticals during drinking water treatment. 
Environ. Sci. Technol. 2002, 36, 3855–3863. 
Water 2012, 4                            
 
 
668
23. Westerhoff, P.; Yoon, Y.; Snyder, S.; Wert, E. Fate of endocrine-disruptor, pharmaceutical, and 
personal care product chemicals during simulated drinking water treatment processes. Environ. 
Sci. Technol. 2005, 39, 6649–6663. 
24. Carvalho, A.P.; Mestre, A.S.; Haro, M.; Ania, C.O. Advanced Methods for the removal of 
acetaminophen from water. In Acetaminophen, properties, clinical uses and adverse effects; 
Javaherian, A., Latifpour, P., Eds.; Nova Science Publishers Inc.: Hauppauge, New York, NY, 
USA, 2012. 
25. Ania, C.O.; Pelayo, J.G.; Bandosz, T.J. Reactive adsorption of penicillin in activated carbons. 
Adsorption 2011, 17, 421–429. 
26. Rúa-Gómez, P.C.; Püttmann, W. Impact of wastewater treatment plant discharge of lidocaine, 
tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater.  
J. Environ. Monitor. 2012, 14, 1391–1399. 
27. Lajaunesse, A.; Gagnon, C.; Sauvé, S. Determination of basic antidepressants and their  
n-desmethyl metabolites in raw sewage and wastewater using solid phase extraction and liquid 
chromatography-tandem mass spectrometry. Anal. Chem. 2008, 80, 5325–5333. 
28. Schultz, M.M.; Furlong, E.T.; Kolpin, D.W.; Werner, S.L.; Schoenfuss, H.L.; Barber, L.B.; 
Blazer, V.S.; Norris, D.O.; Vadja, A.M. Antidepressant pharmaceuticals in two U.S.  
effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish 
neural tissue. Environ. Sci. Technol. 2010, 44, 1918–1925. 
29. Reungoat, J.; Macova, M.; Escher, B.I.; Carswell, S.; Mueller, J.F.; Keller, J. Removal of 
micropollutants and reduction of biological activity in a full scale reclamation plant using 
ozonation and activated carbon filtration. Water Res. 2010, 44, 625–637.  
30. Lee, C.O.; Howe, K.J.; Thomson, B.M. Ozone and biofiltration as an alternative to reverse 
osmosis for removing PPCPs and micropollutants from treated wastewater. Water Res. 2012, 46, 
1005–1014.  
31. Dubinin, M.M. Microporous structures of carbonaceous adsorbents. In Characterization of 
Porous Solids; Greeg, S.J., Sing, K.S.W., Stoecki, H.F., Eds.; Society of Chemical Industry: 
London, UK, 1979. 
32. German Institute for Standardization. Limits of Detection, Identification and Quantitation (in 
German); DIN 32645; German Institute for Standardization: Berlin, Germany, 1994. 
33. German Federal Ministry of Justice. Regulation on Requirements for the Discharge of Wastewater 
into Surface Waters (in German); German Federal Ministry of Justice: Berlin, Germany, 1997. 
34. Cleuvers, M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, 
and acetylsalicylic acid. Ecotoxicol. Environ. Saf. 2004, 59, 309–315. 
35. Siegrist, H.; Joss, A.; Alder, A.; Gobel, A.; Keller, E.; McArdell, C.; Ternes, T.A. 
Micropollutants—New requirements for wastewater treatment (in German). EAWAG News 2003, 
57, 7–10. 
36. Larsen, T.A.; Lienert, J.; Joss, A.; Siegrist, H. How to avoid pharmaceuticals in the aquatic 
environment. J. Biotechnol. 2004, 113, 295–304. 
37. Jones, O.A.H.; Voulvoulis, N.; Lester, J.N. The occurrence and removal of selected pharmaceutical 
compounds in a sewage treatment works utilising activated sludge treatment. Environ. Pollut. 
2007, 145, 738–744. 
Water 2012, 4                            
 
 
669
38. Gomez, M.J.; Bueno, M.J.M.; Lacorte, S.; Fernandez-Alba, A.R.; Aguera, A. Pilot survey 
monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the 
Mediterranean coast. Chemosphere 2007, 66, 993–1002. 
39. Wang, L.; Govind, R. Sorption of toxic organic compounds on wastewater solids: Mechanism and 
modeling. Environ. Sci. Technol. 1993, 27, 152–158. 
40. Ania, C.O.; Bandosz, T.J. Importance of structural and chemical heterogeneity of activated carbon 
surfaces for adsorption of dibenzothiophene. Langmuir 2005, 21, 7752–7759. 
41. Pipe-Martin, C.; Reungoat, J.; Keller, J. Dissolved Organic Carbon Removal by Biological 
Treatment; CRC for Water Quality Research Australia: Adelaide, Australia, 2010. 
42. Nguyen, L.N.; Hai, F.I.; Kang, J.; Price, W.E.; Nghiem, L.D. Removal of trace organic 
contaminants by a membrane bioreactor-granular activated carbon (MBR-GAC) system. 
Bioresour. Technol. 2011, 113, 169–173. 
43. Grünebaum, T. Final Report Phase 1: Elimination of Drug Residues in Sewage Treatment Plants 
(in German); Ministry for Climate Protection, Environment, Agriculture, Nature Conservation and 
Consumer Protection of the German State of North Rhine-Westphalia: Düsseldorf, Germany, 2011. 
44. Schmidt, C.K.; Brauch, H.-J. N,N-dimethylsulfamide as precursor for N-nitrosodimethylamine 
(NDMA) formation upon ozonation and its fate during drinking water treatment. Environ. Sci. 
Technol. 2008, 42, 6340–6346. 
45. SRC PhysProp Database. Available online: http://www.syrres.com/what-we-do/databaseforms.aspx? 
id=386 (accessed on 3 September 2012). 
46. Tzvetkov, M.V.; Saadatmand, A.R.; Lötsch, J.; Tegeder, I.; Stingl, J.C.; Brockmöller, J. 
Genetically polymorphic OCT1: Another piece in the puzzle of the variable pharmacokinetics and 
pharmacodynamics of the opioidergic drug tramadol. Clin. Pharmacol. Ther. 2011, 90, 143–150. 
47. Ellingrod, V.L.; Perry, P.J. Venlafaxine: A heterocyclic antidepressant. Am. J. Hosp. Pharm. 
1994, 51, 3033–3046. 
48. Molconvert, version 5.8.2; Molecule File Conversion with MolConverter; ChemAxon: Budapest, 
Hungary, 2012. 
49. Babić, S.; Horvat, A.J.M.; Pavlović, D.M.; Kaštelan-Macan, M. Determination of pKa values of 
active pharmaceutical ingredients. Trends Anal. Chem. 2007, 26, 1043–1061. 
50. Cabrita, I.; Ruiz, B.; Mestre, A.S.; Fonseca, I.M.; Carvalho, A.P.; Ania, C.O. Removal of an 
analgesic using activated carbons prepared from urban and industrial residues. Chem. Eng. J. 
2010, 163, 249–255. 
51. Ng, A.S.; Stenstrom, M.K. Nitrification in powdered activated carbon-activated sludge process.  
J. Environ. Eng. 1987, 113, 1285–1301. 
52. Serrano, D.; Suárez, S.; Lema, J.M.; Omil, F. Removal of persistent pharmaceutical micropollutants 
from sewage by addition of PAC in a sequential membrane bioreactor. Water Res. 2011, 45, 
5323–5333. 
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
